Legal & General Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.1M | Buy |
|
|||||
|
2025
Q2 | $11.4M | Buy |
|
|||||
|
2025
Q1 | $9.38M | Buy |
|
|||||
|
2024
Q4 | $4.15M | Buy |
|
|||||
|
2024
Q3 | $5.16M | Buy |
|
|||||
|
2024
Q2 | $3.51M | Buy |
|
|||||
|
2024
Q1 | $3.92M | Buy |
|
|||||
|
2023
Q4 | $3.48M | Buy |
|
|||||
|
2023
Q3 | $2.46M | Sell |
|
|||||
|
2023
Q2 | $4.93M | Sell |
|
|||||
|
2023
Q1 | $4.58M | Buy |
|
|||||
|
2022
Q4 | $4.13M | Buy |
|
|||||
|
2022
Q3 | $3.5M | Buy |
|
|||||
|
2022
Q2 | $4.6M | Buy |
|
|||||
|
2022
Q1 | $5.44M | Buy |
|
|||||
|
2021
Q4 | $5.83M | Buy |
|
|||||
|
2021
Q3 | $5.93M | Buy |
|
|||||
|
2021
Q2 | $4.73M | Buy |
|
|||||
|
2021
Q1 | $5.65M | Sell |
|
|||||
|
2020
Q4 | $6.94M | Buy |
|
|||||
|
2020
Q3 | $3.64M | Sell |
|
|||||
|
2020
Q2 | $3.68M | Buy |
|
|||||
|
2020
Q1 | $1.74M | Sell |
|
|||||
|
2019
Q4 | $1.78M | Buy |
|
|||||
|
2019
Q3 | $1.5M | Buy |
|
|||||
|
2019
Q2 | $1.95M | Buy |
|
|||||
|
2019
Q1 | $2.07M | Buy |
|
|||||
|
2018
Q4 | $899K | Buy |
|
|||||
|
2018
Q3 | $1.33M | Buy |
|
|||||
|
2018
Q2 | $1.23M | Sell |
|
|||||
|
2018
Q1 | $1.04M | Sell |
|
|||||
|
2017
Q4 | $7.07M | Buy |
|
|||||
|
2017
Q3 | $957K | Buy |
|
|||||
|
2017
Q2 | $933K | Buy |
|
|||||
|
2017
Q1 | $870K | Buy |
|
|||||
|
2016
Q4 | $873K | Buy |
|
|||||
|
2016
Q3 | $516K | Sell |
|
|||||
|
2016
Q2 | $402K | Hold |
|
|||||
|
2016
Q1 | $502K | Buy |
|
|||||
|
2015
Q4 | $802K | Hold |
|
|||||
|
2015
Q3 | $664K | Buy |
|
|||||
|
2015
Q2 | $641K | Buy |
|
|||||
|
2015
Q1 | $151K | Buy |
|
|||||
|
2014
Q4 | $58K | Hold |
|
|||||
|
2014
Q3 | $76K | Buy |
|